FDA Releases Final Rule to Revise Mammography Quality Standards Act Regulations

The U.S. Food and Drug Administration (FDA) released a final rule updating the agency’s regulatory implementation of the Mammography Quality Standards Act Regulations of 1992 (MQSA). The American College of Radiology® (ACR®) is analyzing the final rule and will release further information for providers and accredited facilities once the review is complete.

The MQSA authorized the FDA to develop standards that would be enforced through strict accreditation, certification and inspection of equipment and personnel at mammography facilities. The ACR, via its Mammography Accreditation Program, is an FDA-approved accreditation body.

The FDA’s final rule makes several revisions to the program, including modifications related to repeated failure to achieve accreditation, breast density notification, record retention, equipment and quality control, and regulatory enforcement, among other issues. The rule goes into effect for mammography facilities Sept. 10, 2024.

Members with questions can contact Gloria Romanelli, JD, ACR Senior Director, Legislative and Regulatory Relations.

Related ACR News

President Biden Issues Executive Order to Advance Women's Health Research and Innovation
The White House released an Executive Order (EO) to Advance Women’s Health Research and Innovation March 18, as part of the Biden Administration’s White House Initiative on Women’s Health Research. The EO directs a multitude of federal agencies to develop and strengthen research and data standards on women’s health across all relevant research and funding opportunities. These actions build on the recent announcement of the Advanced Research Projects Agency for Health Sprint for Women’s Health, which committed $100 million toward transformative research and development in women’s health.
Read more
Partner With ACR in ARPA-H $100 Million Funding Opportunity to Improve Women's Health Outcomes
The Advanced Research Projects Agency for Health (ARPA-H) recently announced the Sprint for Women’s Health, a funding opportunity for researchers to discover unconventional approaches and innovative ways to push high-impact biomedical research forward to improve women’s health outcomes. ARPA-H intends the effort to fundamentally change the trajectory of women’s healthcare research and radically accelerate the next generation of discoveries. A total of $100 million is available through the effort.
Read more
New Mammography Quality Measures Available for Beta Testing
The Centers for Medicare and Medicaid Services (CMS) Measures Management System posted a public comment period, open through Feb. 26, for four new breast cancer-related measures developed by Acumen, LLC.
Read more